Fig. 3: Immune augmentation upon neoadjuvant chemotherapy.
From: Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer
a Relative levels of immunohistochemical staining intensities in all pre-NACT (n = 92) and post-NACT (n = 60) cervical tumour samples. Blue labels: significant decrease; red labels: significant increase; black labels: statistically unchanged. b Relative levels of immunohistochemical staining intensities in paired pre-NACT (n = 43) and post-NACT (n = 43) cervical tumour samples. Blue labels: significant decrease; red labels: significant increase; black labels: statistically unchanged. c Representative images (×20) of immunohistochemical staining in paired pre- and post-NACT cervical tumour samples.
